A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantationMatthew S. Davids, Philippe Armand, Frederick L. Locke et al.|Blood|2020Cited by 98
A Phase I/Ib Study of Nivolumab for Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation (alloHCT)Matthew S. Davids, Philippe Armand, Haesook T. Kim et al.|Blood|2018Cited by 13